"The most curious fact is the perfect gradation in the size of the beaks in the different species of Geospiza, from one as large as that of a hawfinch to that of a chaffinch, and ... even to that of a warbler"

- Charles Darwin, Voyage of the Beagle

Beagle Scientific Inc. (formerly Huen Structure Bio) delivers services in molecular structure analysis, scientific content creation, and curates client-specific solutions in the biotech industry. Our work is backed by our expertise in structural biology, protein engineering and biochemistry. 

The Team

Jen Huen, PhD - Founder and President

Jen obtained her PhD in Biochemistry at the University of Toronto and completed a post-doctorate fellowship in structural and molecular biology at Academia Sinica. She was an antibody scientist at AbCelex Technologies, a clinical-stage company, and led efforts in developing lead nanobody candidates resulting in the publication of the team's work in a peer-reviewed journal. Her experience in protein folding and antibody engineering for infectious diseases and immuno-oncology has garnered awards and fellowships from the National Science and Engineering Research Council of Canada and Southern Ontario Smart Computing for Innovation.

Saumil V. Patel, MPharm - Scientific Project Manager 

With his Masters in Pharmaceutical science, Saumil has over 9 years of industry experience in small molecule testing, quality assurance and R & D of biologics. His work in API testing led to the development of the first ICH-validated method for QC testing of piperine and gingerol. He was an associate scientist at AbCelex Technologies and oversaw protein production by fed-batch fermentation and established a high-throughput platform for nanobody expression and purification. He is experienced in yield optimization, biophysical characterization, method development and is currently managing scientific operations at Beagle Scientific.

Advisory Board

Bernhard Suter, PhD - Business Advisor

Bernhard obtained his PhD in Molecular Biology at ETH Zurich and completed post-doctorate fellowships at UC Berkeley and U of Toronto. With a strong background in proteomics, genetics, and genomics, he has over a decade of experience in R & D, technology and business development, and biotechnology entrepreneurship. He is the founder and CEO of Next Interactions and co-founder and Business Development Director of Stellate DNA. He has extensive expertise in high-throughput interaction screens, next-generation sequencing technologies, and CRISPR genomic engineering. 

Usheer Kanjee, PhD - Scientific Advisor

Usheer obtained his PhD in Biochemistry at U of Toronto and completed a post-doctorate fellowship at Harvard T.H. Chan School of Public Health, where he is currently a research associate. Usheer has considerable experience in microbial and cell biology, parasitology, and structural biology. His work on the bacterial acid stress response and host/parasite interactions of malaria infection is exemplified by his extensive track record of peer-reviewed publications.